SCHEMBL26172959

SCHEMBL26172959

CCCCCCCCCCCOc1ccc2ccccc2c1/N=N/c1ccc(/N=N/c2ccccc2C)cc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 3/20 0.45
▸ THRB P10828 1/20 0.42
▸ TDP1 Q9NUW8 2/20 0.40
▸ CHUK O15111 1/20 0.40
▸ DAPK3 O43293 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ PRKCG P05129 1/20 0.40
▸ CDK1 P06493 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ RPS6KB1 P23443 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ AKT1 P31749 1/20 0.40
▸ AKT2 P31751 1/20 0.40
▸ MAPKAPK2 P49137 1/20 0.40
▸ BLK P51451 1/20 0.40
▸ RPS6KA3 P51812 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ LIMK1 P53667 1/20 0.40
▸ PRKCZ Q05513 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26172960 0.91 THRB (0.44) KCNH2THRBTDP1TP53CYP3A4
SCHEMBL30277702 0.87 GLO1 (0.41) KCNH2THRBTDP1TP53CYP3A4
SCHEMBL26172963 0.82 KCNH2 (0.53) KCNH2THRBTDP1CHUKDAPK3
SCHEMBL12955090 0.81 THRB (0.42) KCNH2THRBTDP1TP53CYP3A4
SCHEMBL23964481 0.77 ALDH1A1 (0.40) THRBTSHRMAPK1SMN1; SMN2KMT2A
SCHEMBL23964331 0.76 ALDH1A1 (0.40) KCNH2THRBTSHRMAPK1SMN1; SMN2
SCHEMBL14130426 0.76 THRB (0.46) THRBTDP1TP53CYP3A4TSHR
SCHEMBL20148509 0.76 POLB (0.36) KCNH2THRBTDP1TP53CYP3A4
SCHEMBL13609834 0.76 THRB (0.45) THRBTDP1TP53CYP3A4TSHR
Scarlet Red SCHEMBL6833437 0.76 THRB (0.72) THRBTDP1TP53CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230181744-A1 COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES FUDAN UNIVERSITY (CN) 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230181744-A1 COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES MAP1LC3B, MAP1LC3A, SQSTM1 KCNH2 4876/4885THRB 1791/4885TDP1 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback